Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Inventory (2020 - 2025)

Historic Inventory for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $10.6 million.

  • GeneDx Holdings' Inventory fell 186.63% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year decrease of 186.63%. This contributed to the annual value of $10.6 million for FY2024, which is 2133.99% up from last year.
  • As of Q3 2025, GeneDx Holdings' Inventory stood at $10.6 million, which was down 186.63% from $11.9 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Inventory registered a high of $44.2 million during Q3 2022, and its lowest value of $8.8 million during Q4 2023.
  • Its 5-year average for Inventory is $20.2 million, with a median of $12.3 million in 2023.
  • Per our database at Business Quant, GeneDx Holdings' Inventory skyrocketed by 4282.13% in 2022 and then plummeted by 7883.55% in 2023.
  • Quarter analysis of 5 years shows GeneDx Holdings' Inventory stood at $33.5 million in 2021, then plummeted by 59.16% to $13.7 million in 2022, then crashed by 35.77% to $8.8 million in 2023, then grew by 21.34% to $10.6 million in 2024, then dropped by 0.76% to $10.6 million in 2025.
  • Its Inventory stands at $10.6 million for Q3 2025, versus $11.9 million for Q2 2025 and $12.7 million for Q1 2025.